HealthCare Global Enterprises Limited announced the Board of Directors approved the introduction of the HCG Employee Stock Option Scheme 2026, allowing the issuance of up to 7,421,455 shares. The board also approved the appointments of Dr. Naveen R. Nagar as Head – Clinical Strategy and Mr. Pankaj Gautam as Chief Information Officer. Unaudited financial results for Q3 2026 were also approved, with revenue from operations reaching ₹63,118 Lakhs.
Leadership Appointments
HealthCare Global Enterprises Limited has appointed key personnel to leadership positions. Dr. Naveen R. Nagar has been named Head – Clinical Strategy, and Mr. Pankaj Gautam has been appointed as Chief Information Officer. These appointments are effective immediately and are expected to bolster the company’s strategic initiatives and operational efficiencies.
ESOP Scheme Introduction
The Board of Directors has approved the HCG Employee Stock Option Scheme 2026, with a provision to issue up to 7,421,455 shares. This scheme is designed to grant Employee Stock Options to eligible employees of the company and its subsidiaries, subject to shareholder approval and other regulatory requirements. Further details regarding the scheme will be disclosed separately.
Q3 2026 Financial Performance (Consolidated)
HealthCare Global Enterprises Limited has released its unaudited consolidated financial results for Q3 2026, reporting revenue from operations of ₹63,118 Lakhs. Other key highlights from the consolidated results include:
Total Income: ₹63,554 Lakhs
Profit before tax: ₹3,834 Lakhs
Profit after tax: ₹1,874 Lakhs
The complete financial results are available on the company website. The Board of Directors meeting was held on February 5, 2026.
Q3 2026 Financial Performance (Standalone)
HealthCare Global Enterprises Limited has released its unaudited standalone financial results for Q3 2026, reporting revenue from operations of ₹34,056 Lakhs.
Total Income: ₹34,515 Lakhs
Profit before tax: ₹1,857 Lakhs
Profit after tax: ₹1,305 Lakhs
Source: BSE
